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Abstract
In this manuscript a synthetic methodology for developing sub 20 nm sized polymeric micellar 
nanoparticle designed for extravascular imaging and therapy is revealed. A simple, one-pot 
method is followed, which involved a rapid co-self assembly of an amphiphilic diblock copolymer 
(PS-b-PAA) and polyoxyethylene (80) sorbitan monooleate in water. Sorbitan monooleate imparts 
stability to the micelles and helps to drive down the particle size below 20 nm. The particles were 
incorporated with a water soluble dye ADS832WS, which absorbs in the near infrared range (λex= 
832nm) for sensitive detection with optical and photoacoustic imaging techniques. A candidate 
lipophilic antiangiogenic therapeutic agent fumagillin was also incorporated with high entrapment 
(>95%) efficiency. We demonstrate the effectiveness of this theranostic platform for real-time 
high-resolution intraoperative photoacoustic imaging for facilitating direct assessment of the 
sentinel lymph nodes (SLN) in breast cancer staging. The technique offers huge potential 
providing faster resection of SLN and may minimize complications caused by axillary exploration 
due to mismarking with dyes or low resolution imaging techniques. Finally, the biodistribution and 
organ accumulation of the intravenously and intradermally injected particles were studied in 
rodent model by optical imaging. Data suggest that intraveneously injected NIR-polymeric 
nanoparticles follow a typical bio-distribution clearance path through the reticuloendothelial 
(RES) system. For the intradermally injected particles, a slower mechanism of clearance was 
noticed.
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1. Introduction
The use of mammography in women has increased the detection of small tumors with fewer 
involved axillary lymph nodes. While advances in all medical imaging modalities have been 
shown to identify suspicious nodes, their incidence of false-negative findings as well as their 
failure to detect small metastases have forced a reliance on microscopic examination at the 
time of axillary lymph node dissection (ALND).[1-2] The importance of accurate lymph node 
assessment is not only essential for disease staging and prognosis, but also fundamental for 
treatment planning decisions. Since breast cancer spreads to one or a few lymph nodes, the 
sentinel lymph node(s) (SLNs), before further metastasing to other axillary nodes, the 
identification and sampling of SLN, known as sentinel node biopsy (SNB), has successfully 
reduced the need for ALND and reduced the associated morbidity.[3-8] Consequently, SLB 
has become widely practiced in the United States, Europe, and Australia.
SLB requires noninvasive detection of SLN, which are marked for intraoperative localization 
and resection with methylene blue dye or radioactive colloid placed preoperatively under 
imaging guidance. SLN dye staining is approximately 90% effective, which can be improved 
to over 95% with radioactive colloid labeling but with added expense and inconvenience of 
intraoperative gamma camera imaging. The most sensitive approach involves radioactive 
colloids, which beyond the safety and handling issues surrounding radioactive materials in 
the operating room, the strong signal provides very low lateral and neglible vertical 
resolution to guide the resection, leading to imprecision in the localization and resection of 
SLN and increasing the potential for adverse surgical effects. For the methylene blue 
approach, there is no intraoperative image guidance and the location and depth of dissection 
must be approximated from pre-operative data. Moreover, allergic reactions to the blue dye 
are the most significant adverse event associated with the SLB.[9] Unfortunately, 
identification of the dye in the operating room can be hampered by changes in SLN 
orientation relative to external landmarks due to patient repositioning at surgery. Real-time 
high-resolution intraoperative imaging using a flexible, portable non-nuclear modality could 
facilitate direct assessment of the SLN location within the axilla independent of the patient 
position on the OR table. With immediate imaging, the resection of SLN would be faster and 
minimize complications caused by axillary exploration due to mismarking with dyes or low 
resolution imaging techniques.
Photoacoustic (PA) or optoacoustic imaging is a non-invasive technique that uniquely 
synergizes optical and ultrasound imaging, providing high spatial resolution imaging in both 
the vertical and lateral planes. [10-11] The technique is based on a phenomenon in which the 
absorbed electromagnetic energy of light is transformed into kinetic energy and localized 
heating releasing a pressure or radiofrequency wave. The optical absorption can be 
associated with endogenous molecules, such as hemoglobin or melanin, or it can be 
achieved through exogenously delivered contrast agents: e.g. optical dyes, gold 
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nanoparticles, single walled carbon nanotube (SWNT).[12-14] Recently, we [15] and other 
groups [16] have recently shown the utility of gold nanoparticles (≤ 90 nm) for preoperatively 
enhancing SLN detection. However, the clinical use of gold is discouraged by the high and 
unpredicatable cost of the metal; moreover, the added patient inconvenience, healthcare cost, 
and small risks involved with preoperative labeling persist.
We hypothesized that PA nanoparticle size and composition would dictate work the 
lymphatic transport behaviour based on prior work with gold nanoparticles. In addition, we 
anticipated that sub 20 nm “soft” polymeric nanoparticles, which are essentially the same 
size as small proteins, such as albumins, would have the most rapid lymphatic transit times 
yet be large enough for retention and phagocytosis by draining cortical macrophages. 
Polymeric nanoparticle at a size range of 15-20 nm would be highly advantageous over other 
previously used nanoplatforms in terms of their safety and facile lymphatic transport. Since 
these particles are meant to traverse rapidly through the lymphatic vessels, they can be 
tracked real-time and may assist direct evaluation of the SLN location. With the help of real 
time imaging, the resection of SLN would be quicker reducing the possibility of post-
operative complications.
Polymeric nanoparticles can be produced in a variety of sizes and shapes.[17-19] In an early 
report, stable nanoparticles (30-40 nm) of polystyrene-b-poly(acrylic acid) (PS-b-PAA) 
copolymers were produced with increased hydrophobic core density though a high 
temperature annealing process.[20] Subsequently, similarly sized particles (~40 nm) targeted 
to folate, αvβ3-integrin, and or labeled with 64Cu, were reported.[21-23] More complicated 
core-shell-corona micelles with a thermoresponsive shell self-assembled by triblock 
copolymer of poly(ethyleneglycol)-b-poly(N-isopropylacrylamide)-b-polystyrene (PEG45-b-
PNIPAM168-b-PS46) (~40 nm) incorporating poly(N-isopropylacrylamide for thermo-
sensitivity were described, to enhance localized drug delivery.[24] These agents, if targeted to 
caveolae for extravascular imaging or drug delivery will encounter significant size-
dependent inefficiency. The objective of the present study was to develop a stable PS-b-PAA 
nano system with a sub 20 nm particle size with broad biomedical potential for extravascular 
imaging and drug delivery in vivo.
2. Results and Discussion
Our design of the polymeric nanoparticle involved a co-self assembly of an amphiphilic 
diblock copolymer and Polyoxyethylene (20) sorbitan monooleate in water. (Scheme 1) 
Sorbitan monooleate was deliberately chosen as a co-surfactant to impart stability to the 
micelles and to restrict the particle diameter within 20 nm with low polydispersity. The 
amphiphilic polymer was PS8-b-PAA400 (Mn×103, 0.8-b-33.0, polydispersity index: 
PDI=1.18, 0.00033 mmol, 0.5 mole%). [25] A simple, “one pot” procedure was followed to 
incorporate a water-soluble near infrared dye (ADS832WS, λex= 824 nm, 1.90 × 105 L 
mol−1 cm−1) as a surrogate photoacoustic payload, which was facilitated by the use of a 
cosurfactant. A facile synthetic route was followed, which involved bath sonication at 50°C 
to prepare the polymeric micelles. In a typical procedure, PS-b-PAA (6 mg) was weighed in 
a long neck test tube and to this polysorbate (1 ml) and ADS832WS (1 mg) were added. To 
this mixture, nano pure water (5 ml, 0.2μm) was added. The mixture was then placed in a 
Pan et al. Page 3
Adv Healthc Mater. Author manuscript; available in PMC 2016 September 29.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
preheated bath, protected from light, and sonicated at ambient temperature. The mixture 
turned transparent within 2 min then the particle suspension was dialyzed against infinite 
sink of nanopure water to remove unbound dye. Ultrasonic bath technique produced a 
heterogeneous mixture of irregular-shaped micelles as evidenced in the anhydrous state with 
transmission electron microscopy (TEM). (Figure 2a) These morphologies reflected, at least 
in part, drying artifacts due to the “soft” compliant nature of the particles. However, the 
difference in hydrophobic chain length between the amphiphilic polymer and the 
polysorbate may have also contributed to the variable micellar conformations.
Multiple analytical techniques were employed to thoroughly characterize these particles. 
Dynamic light scattering (DLS) measurements revealed the number-averaged hydrodynamic 
particle diameter (Dav) as 16 ± 2 nm with polydispersitiy (0.021). Electrophoretic potential 
values (ζ= −10 ± 2 mV) were measured as negative, which confirmed that the surface was 
predominantly occupied by the carboxylic acid groups of the hydrophilic segment of the 
block copolymer. The anhydrous state particle diameter (Dah= 12 ± 04 nm) was calculated 
from TEM based on a measurement of approx. 100 particles. The discrepancy observed in 
diameters from hydrated state (DLS) and anhydrous state measurements is presumably due 
to the flattening of the polymers on the TEM surface. Atomic force microscopy (AFM) in 
anhydrous state revealed a particle height of 15 ± 04 nm. (Figure 2b) UV-Vis spectroscopy 
and fluorescence spectroscopy (λex =824 nm; λem =832 nm) confirmed the absorbencies at 
750-860 nm, corresponding to the presence of the hydrophilic NIR dye. These nanoparticles 
possess long shelf-life stability (40 days at room temperature).
The synthetic compatibility of this polymeric particle with a hydrophobic therapeutic agent 
was evaluated using fumagillin, an antiangiogenic drug. [26] A similar protocol was followed 
as above for the incorporation of the drug, which is highly lipophilic. The precursor agents 
i.e. amphiphilic diblock copolymer and Polyoxyethylene (20) sorbitan monooleate were co-
self assembled in water and the dye was replaced with fumagillin (1 mg). Fumagillin is 
known to degrade on exposure to intense (carbon arc, high in UV) and even under room 
light, both in solution and as the solid, with UV absorbance decreasing with a half-life of 
about 12 hours in solution.[27] Extra precaution was taken to protect the drug and drug 
loaded particles from light. The sample was preserved in amber vials under dark. 
Dissolution studies were performed to measure the drug-retentive qualities of the particles. 
The release of the drug was monitored by UV spectroscopy at λ= 351 nm. Only ~8% 
releases was observed after day one followed by a release of 7% and 3% respectively after 
two and three days. A loading efficiency of approximately 97% was determined with 
excellent retention during dissolution over 4 days in rabbit plasma or against human plasma 
albumin at 37 °C. (Figure 2d) The release of the dye was monitored by UV spectroscopy at 
λ= 824 nm. (Figure 2e)
Optoacoustic or photoacoustic tomographic (PAT) imaging is a hybrid, noninvasive, 
nonionizing modality, which uniquely marries conventional ultrasound and optical imaging. 
A laser pulse is transmitted and absorbed by a biological tissue, a non-radiative de-excitation 
of the absorbed optical energy occurs with a resultant slight increase in temperature due to 
the thermo-elastic expansion. Both endogenous (e.g. haemoglobin) and exogenous (optical 
absorbers e.g. gold nanoparticle, indocyanine green) contrast agents have been used in 
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combination with PAT. [10-15] One of the major advantages of PAT over the conventional 
optical imaging is its ability to image deep vasculature. Wang and co-workers have 
previously demonstrated that optimized PAT could be used to image objects embedded at 
depths of as much as 5.2 cm, 6.2 times the 1/e optical penetration depth, in chicken breast 
muscle at a resolution of <780 μm and a sensitivity of <7 pmol of indocyanine green (ICG) 
in blood.[12b] These results suggest that nonionizing PAT can potentially image deep 
vasculatures in the breast and other organs.
PAT was used to assess the baseline detection of the NIR-doped polymer particles in rat 
whole blood. Figure 2a shows the PA signals obtained from a tygon tube (I.D. 250 μm, O.D. 
500 μm) filled with NIR-polymer nanoparticle and whole rat blood. The laser was tuned to 
750 nm. At this excitation wavelength, the peak-to-peak PA signal amplitude obtained from 
polymer nanoparticle was 320 mV, compared to 130 mV peak-to-peak PA signal amplitude 
from blood alone. Figure 2b shows the PA spectrum (peak-to-peak PA signal amplitude 
versus excitation light wavelength) of the NIR-polymer nanoparticle (in blue) for an 
excitation wavelength range of 720-870 nm. The PA spectrum of rat blood (in red) is also 
shown in the same figure. These results show that the PA signal obtained from polymer 
nanoparticle exceeded the inherent blood signal over the NIR entire bandwidth studied. 
Figure 2c plots the ratio of the peak-to-peak PA signal amplitude of NIR-polymer 
nanoparticle to that of blood between 720 and 870 nm. This experiment demonstrated that 
the NIR polymeric nanoparticles generated strong PA signals beyond that of blood, 
suggesting their utility for in vivo imaging.
As previously discussed, the identification of axilliary lymph nodes through real-time PA 
guidance of sentinel lymph node (SLN) biopsy could decrease resection time by providing 
precise and accurate spatial localization of the SLN, which is poorly achieved with current 
optical and nuclear techniques. In the present study, we evaluated the in vivo stability and 
utility of the polymeric nanoparticles to deliver a NIR dye payload to the sentinel lymph 
node. Figure 3e shows a representative digital photograph of a rat acquired prior to image 
acquisition with its axillary surface shaved for PA imaging. Before the NIR-polymer 
nanoparticle injection, a PA control image was obtained, which is shown in the form of a 
maximum intensity projection (MAP) in figure 3a. The vasculature near an axial node (one 
blood vessel is marked as BV) was clearly imaged, with a good resolution of ~500 μm. Note 
that no lymph nodes were visible in the control image, since the intrinsic optical absorption 
of lymph nodes was negligible without PA contrast. Following intradermal NIR-polymeric 
nanoparticle injection, the PA image MAP of the same area immediately (Figure 3b) 
revealed the lymph node with up to ~510% contrast enhancement which persisted for 30 
minutes. Marked but declining contrast enhancement of the draining lymphnode was 
appreciated for 110 minutes. Figures 3c-d are the post-injection PA images (MAP) of the 
same region 35 min and 110 min after the NIR-polymer nanoparticle injection, respectively. 
The SLN appears approximately in the center of the images, marked as SLN, and was 
clearly visible in all of the post-injection PA images (Figures 3b-d). Figure 3f depicted the 
same rat with the skin removed after the completion of the PA imaging. Figure 3g presents 
the animal following excision of the SLN (arrow in figure 3f). Comparing the excised SLN 
size (3 to 4 mm) with the PA image revealed a close match. (Figures 3b-d).
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These polymeric particles were markedly smaller than the gold nanobeacons previously 
reported for PA sentinel imaging, which was reflected in more rapid particle migration from 
the paw to the axillary node. (Figure 3h). This exceptionally rapid and persistent (110 min) 
enhancement of the sentinal lymphnodes with the polymeric NIR particles suggests that 
flexible, real-time interoperative use rather than the typical perioperative patient procedure 
may be possible. Such an approach offers greater convenience and reduced procedural 
expense, as well as improved surgical advantage given the ability to directly and rapidly 
recognize the depth and orientation of the nodes with intraoperative PAT as the patient is 
positioned on the table for easier resection. In contradistinction, the current most sensitive 
techniques with radio-labeled colloids provide only low lateral plane resolution to guide the 
site of incision but limited vertical resolution to anticipate the depth of dissection required. 
Interestingly, rather than being permanently entrapped or phagocytosed within the 
lymphnodes, the tiny NIR particles retained their structural integrity and migrated out into 
the lymphatic chain and into the circulation via the thoracic duct.
Observance of this interesting behavior prompted us to explore and compare the vascular 
pharmacokinetics and biodistribution of NIR-polymeric nanoparticles injected intravenously 
and intradermally. A bolus dose (1 ml/kg body weight) was injected I.V. and I.D. and mice 
were dynamically imaged with IVIS Spectrum NIR optical imaging system (Caliper Life 
Sciences) every three minutes for thirty minutes. Following I.V. injection, an immediate 
enhancement of the major blood bearing organs (i.e. heart, spleen, liver, kidney, lymph 
nodes) was appreciated. (Figure 4)
Biodistribution of the polymeric nanoparticles were determined at 24 hours post I.V. and 
I.D. injection. Animals (n=3) were sacrificed; major organs were excised and imaged with 
IVIS. For both the I. D. and I. V. injected animals, the liver was the predominant organ of 
nanoparticle accumulation as evident from the measured fluorescence intensity. For I. V. 
injected animals, the other major clearance organs were kidney, lung and lymph node 
whereas spleen and heart did not produce significant fluorescence signal. Spleen, heart, 
kidney and liver were the major sites of nanoparticle accumulation for the I. D. injected 
animal. It is also interesting to note that for the intradermally injected animals, the lymph 
node accumulation was much higher in comparison to the intravenously injected animal. 
(Figure 5) These data suggest NIR-polymeric nanoparticles presumably follow a typical bio-
distribution routes and getting cleared through the reticuloendothelial (RES) system when 
intravenously delivered. For the intradermally injected particles, more overall fluorescence 
signal were seen after 24h, indicating that a slower mechanism of clearance.
3. Conclusions
In conclusion, we report a simple but efficient synthesis of sub-20 nm polymeric 
nanoparticles incorporating therapeutic or contrast payloads. The use of polysorbate as a 
cosurfactant during the self assembly process helped to stabilize the tiny micelles and 
allowed incorporation of both hydrophilic (NIR dye) and hydrophobic (fumagillin) payloads 
with high encapsulation efficiency (>97%). For PAT imaging of sentinel lymph nodes, the 
time to lymph node signal was very high and very rapid, which could accommodate rapid, 
flexible and direct intraoperative use, precluding the need for perioperative procedures and 
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reducing the potential for inadequate or mislabelling. We demonstrate the effectiveness of 
this theranostic platform for real-time high-resolution intraoperative PA imaging, which may 
facilitate direct assessment of the sentinel lymph nodes (SLN) in breast cancer staging. The 
technique offers huge potential providing faster resection of SLN and may minimize 
complications caused by axillary exploration due to mismarking with dyes or low resolution 
imaging techniques. The biodistribution of polymeric nanoparticles intravenously injected in 
rodent models were found to follow the anticipated RES pathway. For intradermally injected 
particles, slower clearance mechanism was observed.
4. Experimental Section
Materials
Unless otherwise listed, all solvents and reagents were purchased from Aldrich Chemical 
Co. (St. Louis, MO) and used as received. Anhydrous chloroform and methanol were 
purchased from Aldrich Chemical Co. Poly(styrene-b-acrylic acid)25 (PS-b-PAA) was 
purchased from Polymer Source Inc. (Montreal, Canada). Polyoxyethylene (20) sorbitan 
monooleate was purchased from Aldrich. Argon and nitrogen (Ultra High Purity: UHP, 
99.99%) were used for storage of materials. The Spectra/Por membrane (Cellulose MWCO: 
20 000 Da) used for dialysis was obtained from Spectrum Medical Industries, Inc. (Laguna 
Hills, CA).
Synthesis of polymeric micelles
Typical procedure for the preparation of dye-loaded (or drug loaded) polymeric micelles: 
Polyoxyethylene (20) sorbitan monooleate (Aldrich, Inc., 1 ml, 0.81 mmol) and PS8-b-
PAA40025 (Mn×10−3: 0.8-b-29.3 polydispersity index: PDI=1.18, 0.00033 mmol, 6.0 mg, 0.5 
mole%) were weighed in a long necked tube. The dye ADS832WS (American Dye Source, 
Inc., 1 mg, absorption coefficient: 1.90 × 105 L mol−1 cm−1) was added to this mixture. To 
this mixture 8 ml of nanopure water (0.2μm) was added then briefly probe sonicated at 
ambient temperature for 2 minutes until a transparent suspension was achieved. The dye-
loaded particles were transferred into 10,000 Da MWCO cellulose membrane dialysis tubing 
and dialyzed against water for 2 days with multiple water exchanges. The nanoparticles were 
recovered, passed through a 0.45 μm Acrodisc Syringe filter into serum vials, sealed under 
argon, and stored at 4°C until use. For drug-loaded particles, the same protocol was followed 
and the dye was replaced with fumagillin (1 mg).
Measurements
Dynamic light scattering measurements (DLS)
Hydrodynamic diameter distribution and distribution averages for the polymeric particles in 
aqueous solutions were determined by dynamic light scattering. Hydrodynamic diameters 
were determined using a Brookhaven Instrument Co. (Holtsville, NY) Model Zeta Plus 
particle size analyzer. Measurements were made following dialysis (MWCO 50 kDa dialysis 
tubing, Spectrum Laboratories, Rancho Dominguez, CA) of nanoparticle suspensions into 
deionized water (0.2 μM). Nanoparticles were dialyzed into water prior to analysis. 
Scattered light was collected at a fixed angle of 90°. A photomultiplier aperture of 400 mm 
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was used, and the incident laser power was adjusted to obtain a photon counting rate 
between 200 and 300 kcps. Only measurements for which the measured and calculated 
baselines of the intensity autocorrelation function agreed to within +0.1% were used to 
calculate nanoparticle hydrodynamic diameter values. All determinations were made in 
multiples of five consecutive measurements.
Electrophoretic potential measurements (Zeta Potential)
Zeta potential (ζ) values for the polymeric particles were determined with a Brookhaven 
Instrument Co. (Holtsville, NY) model Zeta Plus zeta potential analyzer. Measurements 
were made following dialysis (MWCO 50 kDa dialysis tubing, Spectrum Laboratories, 
Rancho Dominguez, CA) of nanoparticles suspensions into water. Data were acquired in the 
phase analysis light scattering (PALS) mode following solution equilibration at 25°C. 
Calculation of ζ from the measured nanoparticle electrophoretic mobility (μ) employed the 
Smoluchowski equation: μ = εζ/η, where ε and η are the dielectric constant and the absolute 
viscosity of the medium, respectively. Measurements of ζ were reproducible to within ±4 
mV of the mean value given by 16 determinations of 10 data accumulations.
Fluorescence Spectroscopy
Fluorescence spectroscopy was performed to confirm the presence of the dye ADS832WS 
within the nanoparticle. Nanoparticle suspension was excited at (λex =824 nm; λex =832 
nm. Fluorescence spectroscopic measurements was made with a Cary Eclipse fluorescence 
spectrophotometer equipped with Cary Eclipse modular software.
Transmission Electron Microscopy Measurements (TEM)
Glow discharged carbon/formvar coated nickel grids were floated on a drop of sample for 2 
mins. Grids were blotted, rinsed quickly in water, and stained in 1% aqueous uranyl acetate 
(UA) for 1 min. Samples were blotted, air dried, and viewed on a Zeiss 902 Electron 
Microscope, and recorded with Kodak E.M. film. Micrographs were collected at 100,000x 
magnification.
Atomic Force Microscopy Measurements (AFM)
A Digital Instruments Dimension 3000 series AFM (calibration date 08/2008) and standard 
Veeco tapping mode silicon probes with platinum-iridium (PtIr) coating were used for 
scanning the samples. Typically, aqueous suspensions of polymeric samples were dried in a 
class 10000-clean room on a clean glass slide for 3h. Once dried, samples were placed on 
the AFM and scanned. Pertinent scanning parameters were as follows: Resonant frequency 
(probe): 60-80 kHz; Example of tip velocity: (4 um/s for 2um), (15 um/s for 5um), (30 um/s 
for 10 um). Aspect ratio: 1:1; Resolution: 512 samples/line, 256 lines.
Animal Research Studies
Guidelines on the care and the use of laboratory animals at Washington University in St. 
Louis were followed for all animal experiments. For sentinel lymphnode imaging, adult 
Sprague Dawley rats (250-350 g) were anesthetized with a mixture of ketamine (85 mg/kg) 
and xylazine (15 mg/kg) and maintained on 0.75-1.0% isoflurane delivered through a 
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calibrated vaporizer. Polymeric nanoparticles were administered (1 ml/kg) intradermally into 
the forepaw of the rat. Optical images were acquired before and after the administration of 
the nanoparticle. During image acquisition, anesthesia was maintained with isoflurane (1 
L/min oxygen and 0.75% isoflurane, Euthanex Corp.) and vital signs and pulse oximetry 
(NONIN Medical INC., 8600V) was monitored continuously. Hydration was maintained by 
infusing 8 ml of 0.9% saline subcutaneously into the animal at a distal site as needed. After 
image acquisition, the animals were euthanized by pentobarbital overdose. For 
biodistribution studies, polymeric nanoparticles were administered (500μl total volume) to 
anesthetized mice (n=3 / route of injection) mice, as described above, by tail vein infusion or 
intradermal injection. After 24 hours the treated mice were sacrificed with a pentobarbital 
overdose and their major organs (i.e., liver, spleen, kidney, heart, lung, spleen, lymph node) 
were excised and imaged ex vivo with a Xenogen IVIS Spectrum imaging system.
Optical Imaging System
In vivo fluorescence images were acquired and analyzed with a Xenogen IVIS Spectrum 
imaging system (Caliper LifeSciences, Hopkinton, MA, USA). During the image 
acquisition, the mice were maintained under isoflurane inhalation anesthesia. The settings 
(excitation, 830 nm; emission, 832 nm; exposure time, 0.5 s; binning factor, 8; f value, 2; 
and field of view, 12.9) were used for imaging acquisitions from the animals intravenously 
injected with fluorescence-labeled micelles.
Photoacoustic Imaging System
Light source: tunable Ti:sapphire laser (720nm, LT-2211A, LOTIS TII) pumped by a Q-
switched Nd:YAG (LS- 2137/2, LOTIS TII); pulse width <15 ns, pulse repetition rate 10 Hz. 
The incident laser fluence on the sample surface was controlled to conform to the American 
National Standards Institute standards. Transducer: 5 MHz central frequency, spherically 
focused, 2.54 cm focal length; 1.91 cm diameter active area element, 72% bandwidth (V308, 
Panametrics-NDT); low-noise amplifier (5072PR, Panametrics-NDT). Data were acquired 
with a digital oscilloscope (TDS 5054, Tektronix).
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Scheme 1. 
Synthesis and characterization of theranostic polymeric micelles: (i) co-self assembly of 
amphiphilic diblock copolymer and sorbitan monooleate, ADS-832-WS (A) and/or 
fumagillin (B), sonication, 25°C, 1 min; (ii) dialysis 10kDa cellulosic membrane, nanopure 
water (0.2 μM).
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Figure 1. 
(a) TEM image of the polymeric micelles drop deposited over nickel grid, scale bar = 100 
nm; (b) AFM image of the micelles drop deposited over glass; (c) physico-chemical 
characterization table for a NIR-polymer micelle; (d) dissolution of ADS-832-WS from 
micelle when incubated against rabbit plasma and human plasma albumin; (e) time-
dependent release of fumagillin from micelle.
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Figure 2. 
PA imaging of NIR polymer nanoparticle against blood. a) PA spectroscopy signals 
generated from a tygon tube (I.D. 250 μm, O.D. 500 μm) filled with NIR-polymer micelle 
and rat blood. The laser was tuned to 750 nm wavelength. b) PA spectrum of NIR-polymer 
micelle and rat blood over a 720–870 nm NIR wavelength range. c) Ratio of the peak-to-
peak PA signal amplitudes generated from polymeric nanoparticle to those of blood.
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Figure 3. 
Non-invasive in vivo PA images of SLN in rat: For all PA images, the laser was tuned to 750 
nm wavelength. a) Control PA image acquired before polymeric nanoparticle injection. 
Bright parts represent optical absorption, here, from blood vessels (BV). b) PA image 
(MAP) acquired immediately after the polymeric nanoparticle injection. c) 35 min post-
injection PA image. d) 110 min post-injection PA imageBlood vessel (BV), lymph vessel 
(LV) and sentinel lymph node (SLN) are marked with arrows, and the SLN is visible in b)– 
d), however, invisible in a). e) Photograph of the rat after the hair was removed from the 
scanning region before taking the PA images. The scanning region is marked with a black 
dotted square. f) Photo-graph of the rat with the skin removed after PA imaging. g) Excised 
lymph node. Smallest tick: 1 mm. h) PA signal enhancement in the SLN after the injection 
of polymeric nanoparticle as a function of post-injection time. For a)-d): FOV = 25 mm × 24 
mm, step size along the X direction = 0.2 mm, step size along the Y direction = 0.4 mm, 
total scan time=~23 min. No signal averaging was used.
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Figure 4. 
In vivo dynamic fluorescence imaging of IV injected polymeric nanoparticle. Images were 
acquired using IVIS spectrum (Caliper) at 3 min interval for 30 min.
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Figure 5. 
In vivo bio-distribution of NIR-polymeric nannoparticles. Organ distribution of the 
nanoparticles based on normalized fluorescent intensities in major organs 24h after 
intravenously (a) and (b) intradermally injected particles; (c) excised major organs (kidney, 
lung, heart, spleen, lymphnodes and liver) collected (i) 2h after intravenouesly injected 
particles; 24h after intradermally (ii) intravenouesly and injected particles (iii). [ID: 
intradermal; IV: intravenous injection]
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